Hepatitis C therapeutics: current status and emerging strategies.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 11, p. 867, doi. 10.1038/nrd937
- By:
- Publication type:
- Article
Works matching IS 14741776 AND DT 2002 AND VI 1 AND IP 11
Results: 21
1
2
Innovation: Hepatitis C virus replicons: potential role for drug development.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 11, p. 911, doi. 10.1038/nrd942
- By:
- Publication type:
- Article
3
Therapeutic strategies for Alzheimer's disease.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 11, p. 859, doi. 10.1038/nrd938
- By:
- Publication type:
- Article
4
The future challenges facing the development of new antimicrobial drugs.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 11, p. 895, doi. 10.1038/nrd940
- By:
- Publication type:
- Article
5
Integration of virtual and high-throughput screening.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 11, p. 882, doi. 10.1038/nrd941
- By:
- Publication type:
- Article
6
Structure-based drug design: Complex is crystal clear.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 11, p. 842, doi. 10.1038/nrd952
- By:
- Publication type:
- Article
7
Biotechnology: Turn it off.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 11, p. 842, doi. 10.1038/nrd948
- By:
- Publication type:
- Article
8
Designing peptide receptor agonists and antagonists.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 11, p. 847, doi. 10.1038/nrd939
- By:
- Publication type:
- Article
9
Correction.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 11, p. 920
- By:
- Publication type:
- Article
10
Lead generation: Alternative route.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 11, p. 841, doi. 10.1038/nrd945
- By:
- Publication type:
- Article
11
Anticoagulants: Balance control.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 11, p. 842, doi. 10.1038/nrd947
- By:
- Publication type:
- Article
12
Outlook: Drug advertising: the right or wrong prescription for our ailments?
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 11, p. 916, doi. 10.1038/nrd943
- By:
- Publication type:
- Article
13
From the analyst's couch: The evolution of biotech.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 11, p. 845, doi. 10.1038/nrd944
- By:
- Publication type:
- Article
14
Analgesics: Time for a new COX?
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 11, p. 839, doi. 10.1038/nrd951
- By:
- Publication type:
- Article
15
Cardiovascular disease: Macrophage LXRs inhibit atherosclerosis.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 11, p. 840, doi. 10.1038/nrd946
- By:
- Publication type:
- Article
16
Autoimmune disease: Lesions with a jagged edge.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 11, p. 840, doi. 10.1038/nrd949
- By:
- Publication type:
- Article
17
Protein structure: Folding forecast.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 11, p. 843, doi. 10.1038/nrd953
- By:
- Publication type:
- Article
18
In Brief.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 11, p. 843, doi. 10.1038/nrd954
- Publication type:
- Article
19
Patent Watch.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 11, p. 844
- Publication type:
- Article
20
Easing the chemistry bottleneck: careers in high-throughput chemistry.
- Published in:
- Nature Reviews Drug Discovery, 2002, v. 1, n. 11, p. 925, doi. 10.1038/nrd957
- By:
- Publication type:
- Article
21
Interdisciplinary equilibrium.
- Published in:
- 2002
- Publication type:
- Editorial